Target intelligence / Profile preview

Vascular endothelial niche

Molecular classification
Other
01

Overview

The vascular endothelial niche is a specialized microenvironment primarily composed of endothelial cells, pericytes, and the surrounding extracellular matrix. It serves as a critical regulatory hub for stem cell populations, particularly hematopoietic stem cells in the bone marrow, by providing essential paracrine signals—often termed angiocrine factors—that govern quiescence, self-renewal, and differentiation (Butler et al., 2010; Rafii et al., 2016). This niche is not a single molecule but a complex system that integrates physical cues and biochemical signaling to maintain tissue homeostasis. In pathological states, such as cancer, the vascular niche is frequently co-opted to support tumor growth, facilitate metastasis, and provide a protective sanctuary that shields malignant cells from chemotherapy (Poulos et al., 2017). Therapeutic strategies targeting the vascular endothelial niche aim to disrupt these supportive interactions or mobilize sequestered cells into the circulation to enhance the efficacy of cytotoxic treatments (Winkler et al., 2012). Common molecular targets within this niche include the VEGF/VEGFR axis, Notch signaling, and the CXCR4/SDF-1 pathway, which are vital for maintaining the structural and functional integrity of the vascular environment (Himburg et al., 2012).

Other names
Endothelial nichePerivascular nicheVascular nicheVascular stem cell niche
02

Mechanism of action

Modulation of the microenvironment through inhibition of angiocrine signaling (e.g., VEGF blockade), disruption of cell-niche adhesion (e.g., CXCR4 or E-selectin antagonism), or mobilization of stem/progenitor cells into the systemic circulation.

03

Biological functions

Signal transductionCell proliferationStem cell maintenanceHematopoiesisAngiogenesisOther
04

Disease associations

CancerCardiovascular diseaseHematological malignanciesInflammationOther
05

Safety considerations

Impaired wound healingHypertensionThromboembolismHemorrhageDisruption of normal hematopoietic homeostasis
06

Interacting drugs

Bevacizumab

4 more in the full profile.

07

Biomarkers

CD31 (PECAM-1)von Willebrand factor (vWF)Vascular endothelial growth factor (VEGF)E-selectin (CD62E)CD144 (VE-cadherin)

Beyond the preview

Go deeper on Vascular endothelial niche.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular endothelial niche.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call